Exclusion Criteria
Co-existing Condition:
Patients with the following conditions or symptoms are excluded:
- Oral candida infection documented by morphology or by response to antifungal therapy within 2 months prior to study entry.
- Temperature > 37.8 degrees Centigrade.
- Malignancy other than cutaneous basal cell carcinoma or cervical carcinoma in situ.
- Significant chronic underlying medical illnesses which would prevent continuous participation in this clinical trial.
Concurrent Medication:
Excluded:
-
Patients with the following are excluded:
- Significant chronic underlying medical illnesses which would prevent continuous participation in this clinical trial.
- Unwilling to sign informed consent.
- Intolerant to zidovudine (AZT).
- Oral hairy leukoplakia at any time prior to study entry.
Prior Medication:
Excluded within 7 days of study entry:
- Antiretroviral drugs.
- Immunomodulators.
- Excluded within 30 days of study entry:
- Any investigational drugs.
Patients have the following: